Toshimasa Nakada

Parameters to Guide Rescue Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease

Toshimasa Nakada · Journal of Advances in Medicine and Medical Research · 2017

Aims: To identify the most useful parameter to guide rescue therapy among the IVIG-resistant patients who received an initial single IVIG therapy dose with a delayed use of anti-inflammatory drugs (DUA) for Kawasaki disease. Methods: The parameters of 174 patients who received th...

Open access Research Article 10.9734/JAMMR/2017/35081

Outcomes of Older Children with Kawasaki Disease Who Received Intravenous Immunoglobulin Therapy with Delayed Use of Anti-inflammatory Drugs

Toshimasa Nakada · Journal of Advances in Medicine and Medical Research · 2017

Background: The prevalence of coronary artery lesions (CAL) is higher in older children compared with younger children. Anti-inflammatory drugs including aspirin appeared to have a negative impact on the suppressive effects of initial intravenous immunoglobulin (IVIG) therapy for...

Open access Research Article 10.9734/JAMMR/2017/34047